"NADH Dehydrogenase" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A flavoprotein and iron sulfur-containing oxidoreductase that catalyzes the oxidation of NADH to NAD. In eukaryotes the enzyme can be found as a component of mitochondrial electron transport complex I. Under experimental conditions the enzyme can use CYTOCHROME C GROUP as the reducing cofactor. The enzyme was formerly listed as EC 1.6.2.1.
| Descriptor ID |
D009245
|
| MeSH Number(s) |
D08.811.682.608.504.500 D12.776.157.427.374.375.863.500 D12.776.331.887 D12.776.556.579.374.375.140.500
|
| Concept/Terms |
NADH Dehydrogenase- NADH Dehydrogenase
- Dehydrogenase, NADH
- NADH Cytochrome c Oxidoreductase
- Diaphorase (NADH Dehydrogenase)
- NADH (Acceptor) Oxidoreductase
- NADH Cytochrome c Reductase
|
Below are MeSH descriptors whose meaning is more general than "NADH Dehydrogenase".
Below are MeSH descriptors whose meaning is more specific than "NADH Dehydrogenase".
This graph shows the total number of publications written about "NADH Dehydrogenase" by people in this website by year, and whether "NADH Dehydrogenase" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 1 | 1 |
| 1997 | 0 | 1 | 1 |
| 1998 | 1 | 0 | 1 |
| 1999 | 1 | 0 | 1 |
| 2003 | 1 | 0 | 1 |
| 2004 | 2 | 0 | 2 |
| 2011 | 0 | 1 | 1 |
| 2019 | 1 | 1 | 2 |
| 2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "NADH Dehydrogenase" by people in Profiles.
-
A Case of Infantile Mitochondrial Cardiomyopathy Treated with a Combination of Low-Dose Propranolol and Cibenzoline for Left Ventricular Outflow Tract Stenosis. Int Heart J. 2022 Sep 30; 63(5):970-977.
-
Association of plasma mitochondrial DNA with COPD severity and progression in the SPIROMICS cohort. Respir Res. 2021 Apr 26; 22(1):126.
-
Pathogenic Bi-allelic Mutations in NDUFAF8 Cause Leigh Syndrome with an Isolated Complex I Deficiency. Am J Hum Genet. 2020 01 02; 106(1):92-101.
-
Teaching NeuroImages: Substantia nigra T2 hyperintensities in a man with Leber hereditary optic neuropathy. Neurology. 2019 11 05; 93(19):e1830-e1831.
-
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease. Hum Mol Genet. 2019 06 01; 28(11):1837-1852.
-
Reply to the Letter, "Leigh syndrome with spinal cord involvement due to a hemizygous NDUFA1 mutation". Brain Dev. 2019 Feb; 41(2):224.
-
Papaverine and its derivatives radiosensitize solid tumors by inhibiting mitochondrial metabolism. Proc Natl Acad Sci U S A. 2018 10 16; 115(42):10756-10761.
-
Leigh syndrome with spinal cord involvement due to a hemizygous NDUFA1 mutation. Brain Dev. 2018 Jun; 40(6):498-502.
-
A Role for Mitochondrial Translation in Promotion of Viability in K-Ras Mutant Cells. Cell Rep. 2017 07 11; 20(2):427-438.
-
Identification of a second mimicry epitope from Acanthamoeba castellanii that induces CNS autoimmunity by generating cross-reactive T cells for MBP 89-101 in SJL mice. Int Immunol. 2011 Dec; 23(12):729-39.